These findings amongst others highlight the potential relevance of ghrelin for controlling metabolism as a novel pharmacological target for obesity, insulin resistance, fatty liver disease and T2DM (9, 10). The gene discussed is GHRL; the disease is type 2 diabetes mellitus.